Logo-aim
Arch Iran Med. 25(11):765-766. doi: 10.34172/aim.2022.121

Letter to the Editor

Reporting 12 Cases of Maternal Mortality Due to COVID-19; the Role of Termination of Pregnancy as a Double-Edged Sword

Marjan Ghaemi Conceptualization, 1 ORCID logo
Sedigheh Hantoushzadeh Conceptualization, Writing – original draft, 1
Reza Ghanbari Methodology, 2
Zohreh Heidary Writing – original draft, 1, * ORCID logo

Author information:
1Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran
2Gene Therapy Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

*Corresponding Author: Zohreh Heidary, Email: z.heidary2016@gmail.com

Copyright and License Information

© 2022 The Author(s).
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite this article as: Ghaemi M, Hantoushzadeh S, Ghanbari R, Heidary Z. Reporting 12 cases of maternal mortality due to COVID-19; the role of termination of pregnancy as a double-edged sword. Arch Iran Med. 2022;25(11):765-766. doi: 10.34172/aim.2022.121


Dear Editor,

After publishing our last article entitled “maternal and neonatal complications, outcomes and possibility of vertical transmission in Iranian women with COVID-19”1 that was published in your valuable journal, we wanted to share our last experience of 12 cases of mortalities due to COVID-19 in pregnant women from January 2021 to July 2021 in a single referral hospital in Iran.

Pregnant women with COVID-19 are more likely than normal pregnancies to have preterm birth as well as cesarean section. The rate of neonatal intensive care unit (NICU) admission for their neonates is higher, a well.2 The results of the previous studies have been contradictory. In some studies, the rates of hospitalization in the intensive care unit (ICU) and mechanical ventilation were higher, although the mortality rate did not increase in comparison with non-pregnant cases. Most women recover without undesirable outcomes, but severe maternal complications as well as maternal and prenatal mortalities have been also reported from COVID-19.3

Here, we report 12 maternal mortalities due to COVID-19 infection in pregnant women. Their vital signs, laboratory data and the delivery mode are listed in Table 1. All women required intensive care unit admission. Totally, 7/12 (58.3%) of the cases were in trimester 3 and the others were in the second trimester. No maternal death before 20 weeks was reported. Most terminations except one were via cesarean section. Half of the women died shortly after pregnancy termination due to fetal or maternal distress. Four newborns remained alive and all were preterm but no history of their COVID-19 test was available. In the other cases where the pregnancy did not terminate, most fetuses were expired due to maternal distress. A severe drop in oxygen saturation and hemoglobin decrease in these individuals can expose the fetus to hypoxia and death.


Table 1. Vital Signs, Fetal Status and the Delivery Mode of 12 Maternal Mortalities Due to COVID-19 Infection in Pregnant Women
Age
(y)
Gravidity O2 sat (%) BP (Sys/Dias) PR Temp RR GA Symptoms & Signs Maternal Terminal Manifestation GA in Termination Termination type Cause of Termination Apgar (5-10 min) or Fetal Status
26 G2P1 89 110/80 120 38.3 24 34 Fever, cough, myalgia and dyspnea ARDS 34 C/S Fetal distress 7
38 G3P1Ab1 98 100/60 98 39 24 25 Fever, chills, myalgia and coughs ARDS
39 G2P1 88 97/60 111 39.5 40 22 Nausea, dyspnea ARDS
35 G6Ab5 90 119/77 140 38.3 24 31 Fever, cough, dyspnea ARDS, hematuria 32 Vaginal misoprostol IUFD IUFD
30 G2P1 92 100/76 100 38.5 35 29 dyspnea ARDS 29 C/S fetal distress 1
32 G2P1 60 108/68 120 39.5 40 34 Dyspnea emphysema 35 C/S fetal distress
28 G2P1 78 124/86 120 39 24 26 Dyspnea Cardiac arrhythmia IUFD
29 G3P2 95 110/65 90 37.9 18 35 Cough, dyspnea, decreased smell and taste ARDS 35 C/S Uterine contraction 6
21 G1 92 160/110 98 38 22 21 Cough, dyspnea ARDS, Proteinuria-DIC IUFD
22 G1 95 100/60 86 37.5 20 32 Cough, dyspnea ARDS 32 C/S Fetal distress 7
31 G2p1 80 100/60 128 39.1 40 35 Drowsiness ARDS 35 C/S Fetal distress 2-9

O2 sat, O2 saturation; PR, Pulse rate; RR, Respiratory rate; Temp, Temperature; GA, Gestational age; IUFD, Intra uterine fetal death; CS: Cesarean section; BS, Blood sugar; Cr, Creatinine; Hb, Hemoglobin; Plt, Platelet; Sys/Dias, Systolic/diastolic; G, Gravid; P, Para; Ab, Abortion; ARDS, Acute respiratory distress syndrome; DIC, Disseminated intravascular coagulation; IVIG, Intravenous immunoglobulin; WBC, White blood cells; Nut/lymph, Neutrophil to lymphocyte ration; ESR, Erythrocyte sedimentation rate; CRP, C-reactive protein

*All vital signs are from their first visit in the hospital.

On the other hand, the effect of pregnancy on the general condition of mothers is also important. The Royal College of Obstetricians and Gynecologists recommended the mode of delivery to be primarily determined by the obstetric symptoms and mentions that mothers with COVID-19 and their infants should be separated.4 Other evidence suggests that cytokine storm is responsible for severe symptoms and mortality in patients with COVID-19 rather than the virus itself. Therefore, cytokine storms during delivery seem to worsen the condition of the mothers. It seems that delivery is like a double-edged sword for mothers. On the one hand, it worsens the condition of mothers, and on the other hand, the risk of fetal distress and demise would be inevitable.


Competing Interests

The authors declare that they have no conflict of interest.

Ethical Approval

The study was approved by the Ethics Committee of Tehran University of Medical Sciences (Ethics Code: IR.TUMS.IKHC.REC.1400.351).

Funding

None.


References

  1. Heidary Z, Kohandel Gargari O, Fathi H, Zaki-Dizaji M, Ghaemi M, Hossein Rashidi B. Maternal and neonatal complications, outcomes and possibility of vertical transmission in Iranian women with COVID-19. Arch Iran Med 2021; 24(9):713-21. doi: 10.34172/aim.2021.104 [Crossref] [ Google Scholar]
  2. Smith V, Seo D, Warty R, Payne O, Salih M, Chin KL. Maternal and neonatal outcomes associated with COVID-19 infection: a systematic review. PLoS One 2020; 15(6):e0234187. doi: 10.1371/journal.pone.0234187 [Crossref] [ Google Scholar]
  3. Hantoushzadeh S, Abdollah Shamshirsaz A, Aleyasin A, Seferovic MD, Kazemi Aski S, Arian SE, et al. Maternal death due to COVID-19. Am J Obstet Gynecol 2020;223(1):109.e1-109.e16. 10.1016/j.ajog.2020.04.030.
  4. Royal College of Obstetricians and Gynaecologists (RCOG). Coronavirus (COVID-19) Infection and Pregnancy. RCOG; 2020. Accessed 2021.
Submitted: 03 Nov 2021
Revised: 19 Feb 2022
Accepted: 20 Feb 2022
First published online: 01 Nov 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract View: 891
PDF Download: 478
Full Text View: 28